MSB 2.03% $1.45 mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-220

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    @benelong
    "But almost 100% of anti-MSB posts are unsubstantiated garbage."

    Typical,
    You would say that and given that your posts have been exposed multiple times for misinformation. misinterpretation and ignorance, this is quite ironic.....especially given what has come to pass Mesoblast over last 2.5 years.

    From world firsts to latest P2 GvHD protocol case in point. first visit back since Jan...
    gets embarrassing.

    Last edited by Sector: 27/11/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.